106 related articles for article (PubMed ID: 2297630)
1. Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?
Buzdar AU; McNeese MD; Hortobagyi GN; Smith TL; Kau S; Fraschini G; Hug V; Ellerbroek N; Holmes FA; Ames F
Cancer; 1990 Feb; 65(3):394-9. PubMed ID: 2297630
[TBL] [Abstract][Full Text] [Related]
2. Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.
Hortobagyi GN; Ames FC; Buzdar AU; Kau SW; McNeese MD; Paulus D; Hug V; Holmes FA; Romsdahl MM; Fraschini G
Cancer; 1988 Dec; 62(12):2507-16. PubMed ID: 3056604
[TBL] [Abstract][Full Text] [Related]
3. Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control.
Albert JM; Buzdar AU; Guzman R; Allen PK; Strom EA; Perkins GH; Woodward WA; Hoffman KE; Tereffe W; Hunt KK; Buchholz TA; Oh JL
Breast Cancer Res Treat; 2011 Jul; 128(2):421-7. PubMed ID: 21553292
[TBL] [Abstract][Full Text] [Related]
4. Combined chemotherapy and radiotherapy for patients with breast cancer and extensive nodal involvement.
Ung O; Langlands AO; Barraclough B; Boyages J
J Clin Oncol; 1995 Feb; 13(2):435-43. PubMed ID: 7844606
[TBL] [Abstract][Full Text] [Related]
5. Premenopausal breast cancer patients treated with conservative surgery, radiotherapy and adjuvant chemotherapy have a low risk of local failure.
Rose MA; Henderson IC; Gelman R; Boyages J; Gore SM; Come S; Silver B; Recht A; Connolly JL; Schnitt SJ
Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):711-7. PubMed ID: 2777660
[TBL] [Abstract][Full Text] [Related]
6. Locally advanced non-metastatic breast cancer: analysis of prognostic factors in 125 patients homogeneously treated with a combined modality approach.
Gardin G; Rosso R; Campora E; Repetto L; Naso C; Canavese G; Catturich A; Corvò R; Guenzi M; Pronzato P
Eur J Cancer; 1995; 31A(9):1428-33. PubMed ID: 7577066
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.
Buzdar AU; Singletary SE; Valero V; Booser DJ; Ibrahim NK; Rahman Z; Theriault RL; Walters R; Rivera E; Smith TL; Holmes FA; Hoy E; Frye DK; Manuel N; Kau SW; McNeese MD; Strom E; Thomas E; Hunt K; Ames F; Berry D; Hortobagyi GN
Clin Cancer Res; 2002 May; 8(5):1073-9. PubMed ID: 12006521
[TBL] [Abstract][Full Text] [Related]
8. Surgical conservation planning after neoadjuvant chemotherapy for stage II and operable stage III breast carcinoma.
Kuerer HM; Singletary SE; Buzdar AU; Ames FC; Valero V; Buchholz TA; Ross MI; Pusztai L; Hortobagyi GN; Hunt KK
Am J Surg; 2001 Dec; 182(6):601-8. PubMed ID: 11839324
[TBL] [Abstract][Full Text] [Related]
9. Management of inflammatory carcinoma of the breast. A combined modality approach.
Fastenberg NA; Martin RG; Buzdar AU; Hortobagyi GN; Montague ED; Blumenschein GR; Jessup JM
Am J Clin Oncol; 1985 Apr; 8(2):134-41. PubMed ID: 3841746
[TBL] [Abstract][Full Text] [Related]
10. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial.
Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K
N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428
[TBL] [Abstract][Full Text] [Related]
11. Fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus FAC followed by weekly paclitaxel as adjuvant therapy for high-risk, node-negative breast cancer: results from the GEICAM/2003-02 study.
Martín M; Ruiz A; Ruiz Borrego M; Barnadas A; González S; Calvo L; Margelí Vila M; Antón A; Rodríguez-Lescure A; Seguí-Palmer MA; Muñoz-Mateu M; Dorca Ribugent J; López-Vega JM; Jara C; Espinosa E; Mendiola Fernández C; Andrés R; Ribelles N; Plazaola A; Sánchez-Rovira P; Salvador Bofill J; Crespo C; Carabantes FJ; Servitja S; Chacón JI; Rodríguez CA; Hernando B; Álvarez I; Carrasco E; Lluch A
J Clin Oncol; 2013 Jul; 31(20):2593-9. PubMed ID: 23733779
[TBL] [Abstract][Full Text] [Related]
12. Ten-year results of FAC adjuvant chemotherapy trial in breast cancer.
Buzdar AU; Kau SW; Smith TL; Hortobagyi GN
Am J Clin Oncol; 1989 Apr; 12(2):123-8. PubMed ID: 2705401
[TBL] [Abstract][Full Text] [Related]
13. Multimodal treatment for inflammatory breast cancer.
Thoms WW; McNeese MD; Fletcher GH; Buzdar AU; Singletary SE; Oswald MJ
Int J Radiat Oncol Biol Phys; 1989 Oct; 17(4):739-45. PubMed ID: 2487034
[TBL] [Abstract][Full Text] [Related]
14. [Risk of cardiotoxicity of combination treatment radiotherapy and chemotherapy of locally advanced breast carcinoma stage III].
Bustová I
Klin Onkol; 2009; 22(1):17-21. PubMed ID: 19534435
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trial.
Buzdar AU; Blumenschein GR; Smith TL; Powell KC; Hortobagyi GN; Yap HY; Schell FC; Barnes BC; Ames FC; Martin RG
Cancer; 1984 Feb; 53(3):384-9. PubMed ID: 6362814
[TBL] [Abstract][Full Text] [Related]
16. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
White R; Dinneen T; Makris A
Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
[TBL] [Abstract][Full Text] [Related]
17. Combined modality approach in breast cancer with isolated or multiple metastases.
Buzdar AU; Blumenschein GR; Montague ED; Hortobagyi GN; Yap HY; Pinnamaneni K; Marcus CE; Smith TL
Am J Clin Oncol; 1984 Feb; 7(1):45-50. PubMed ID: 6364779
[TBL] [Abstract][Full Text] [Related]
18. Management of locoregional recurrent breast cancer.
Janjan NA; McNeese MD; Buzdar AU; Montague ED; Oswald MJ
Cancer; 1986 Oct; 58(7):1552-6. PubMed ID: 3755648
[TBL] [Abstract][Full Text] [Related]
19. A prospective, randomized Phase III trial comparing combination chemotherapy with cyclophosphamide, doxorubicin, and 5-fluorouracil with vinorelbine plus doxorubicin in the treatment of advanced breast carcinoma.
Blajman C; Balbiani L; Block J; Coppola F; Chacon R; Fein L; Bonicatto S; Alvarez A; Schmilovich A; Delgado FM
Cancer; 1999 Mar; 85(5):1091-7. PubMed ID: 10091793
[TBL] [Abstract][Full Text] [Related]
20. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation.
Katz A; Strom EA; Buchholz TA; Thames HD; Smith CD; Jhingran A; Hortobagyi G; Buzdar AU; Theriault R; Singletary SE; McNeese MD
J Clin Oncol; 2000 Aug; 18(15):2817-27. PubMed ID: 10920129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
